![Mineralys Therapeutics](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2023/02/mineralys-therapeutics.jpg?resize=735%2C400&ssl=1)
Mineralys Therapeutics Completes Enrollment for Explore-CKD Phase 2 Trial
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the completion of enrollment for its Explore-CKD Phase 2 trial. The study is evaluating the efficacy and safety of lorundrostat, …
Mineralys Therapeutics Completes Enrollment for Explore-CKD Phase 2 Trial Read More